{"title":"唾液有可能成为神经退行性疾病新的金标准样本。","authors":"G. Orive, F. Lopera, E. Carro","doi":"10.3233/jad-220144","DOIUrl":null,"url":null,"abstract":"Gorka Orivea,b,c,∗, Francisco Loperad and Eva Carroe,f,∗ aLaboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria, Spain bBioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain cNetworking Center for Biomedical Research in Bioengineering Biomaterials and Nanomedicine (CIBER-BBN) Barcelona, Spain dGrupo de Neurociencias, Universidad de Antioquia. Medellı́n, Colombia eNeurobiology of Alzheimer’s Disease Unit, Chronic Disease Programme, Instituto de Salud Carlos III, Madrid, Spain f Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Spain","PeriodicalId":219895,"journal":{"name":"Journal of Alzheimer's disease : JAD","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Saliva is a Good Candidate to be the New Gold-Standard Sample for Neurodegenerative Diseases.\",\"authors\":\"G. Orive, F. Lopera, E. Carro\",\"doi\":\"10.3233/jad-220144\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gorka Orivea,b,c,∗, Francisco Loperad and Eva Carroe,f,∗ aLaboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria, Spain bBioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain cNetworking Center for Biomedical Research in Bioengineering Biomaterials and Nanomedicine (CIBER-BBN) Barcelona, Spain dGrupo de Neurociencias, Universidad de Antioquia. Medellı́n, Colombia eNeurobiology of Alzheimer’s Disease Unit, Chronic Disease Programme, Instituto de Salud Carlos III, Madrid, Spain f Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Spain\",\"PeriodicalId\":219895,\"journal\":{\"name\":\"Journal of Alzheimer's disease : JAD\",\"volume\":\"47 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Alzheimer's disease : JAD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3233/jad-220144\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Alzheimer's disease : JAD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/jad-220144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
摘要
Gorka Orivea,b,c,∗,Francisco Loperad和Eva Carroe,f, *药学和制药技术实验室,巴斯克大学/尤斯卡尔Herriko大学(UPV/EHU),维多利亚,西班牙;bioaraba, NanoBioCel研究小组,维多利亚- gasteiz,西班牙;生物工程生物材料和纳米医学生物医学研究网络中心(CIBER-BBN),巴塞罗那,西班牙;西班牙马德里Salud Carlos III研究所慢性疾病规划阿尔茨海默病神经神经生物学部门;西班牙神经退行性疾病生物医学研究网络中心(CIBERNED)
Saliva is a Good Candidate to be the New Gold-Standard Sample for Neurodegenerative Diseases.
Gorka Orivea,b,c,∗, Francisco Loperad and Eva Carroe,f,∗ aLaboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria, Spain bBioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain cNetworking Center for Biomedical Research in Bioengineering Biomaterials and Nanomedicine (CIBER-BBN) Barcelona, Spain dGrupo de Neurociencias, Universidad de Antioquia. Medellı́n, Colombia eNeurobiology of Alzheimer’s Disease Unit, Chronic Disease Programme, Instituto de Salud Carlos III, Madrid, Spain f Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Spain